Literature DB >> 31337448

Protein supplementation combined with low-intensity resistance training in geriatric medical patients during and after hospitalisation: a randomised, double-blind, multicentre trial.

Josephine Gade1,2, Anne Marie Beck2,3, Hanne E Andersen4, Britt Christensen5, Finn Rønholt6, Tobias W Klausen7, Anders Vinther8, Arne Astrup1.   

Abstract

Sarcopenia (loss of muscle mass/strength) burdens many older adults - hospitalised older adults being particularly vulnerable. Treating the condition, protein supplementation (PrS) and resistance training (RT) may act synergistically. Therefore, this block-randomised, double-blind, multicentre intervention study, recruiting geriatric patients > 70 years from three medical departments, investigated the effect of PrS combined with RT during hospitalisation and 12 weeks after discharge. Participants were randomly allocated (1:1) to receive PrS (totally 27·5 g whey protein/d, about 2000 kJ/d) or isoenergetic placebo-products (< 1·5 g protein/d) divided into two servings per d to supplement the habitual diet. Both groups were engaged in a standardised, progressive low-intensity RT programme for the lower extremities (hospital: supervised daily/after discharge: self-training 4×/week). From April 2016 to September 2017, 2351 patients were screened, 462 were eligible, and 165 included. Fourteen were excluded and ten dropped out, leaving 141 participants in the intention-to-treat analysis. The average total protein intake during hospitalisation/after discharge was 1·0 (interquartile range (IQR) 0·8, 1·3)/1·1 (IQR 0·9, 1·3) g/kg per d (protein-group) and 0·6 (IQR 0·5, 0·8)/0·9 (IQR 0·6, 1·0) g/kg per d (placebo group). Both groups improved significantly for the primary and secondary endpoints of muscle mass/strength, functional measurements and quality of life, but no additional effect of PrS was seen for the primary endpoint (30-s chair stand test, repetitions, median changes from baseline: (standard test: 0 (IQR 0, 5) (protein group) v. 2 (IQR 0, 6) (placebo group) and modified test: 2 (IQR 0, 5) (protein group) v. 2 (IQR -1, 5) (placebo group)) or any secondary endpoints (Mann-Whitney U tests, P > 0·05). In conclusion, PrS increasing the total protein intake by 0·4 and 0·2 g/kg per d during hospitalisation and after discharge, respectively, does not seem to increase the adaptive response to low-intensity RT in geriatric medical patients.

Entities:  

Keywords:  Milk-based protein; Muscle mass; Muscle strength; Older adults; Physical function; Rehabilitation; Sarcopenia

Mesh:

Substances:

Year:  2019        PMID: 31337448     DOI: 10.1017/S0007114519001831

Source DB:  PubMed          Journal:  Br J Nutr        ISSN: 0007-1145            Impact factor:   3.718


  4 in total

Review 1.  Effects of branched-chain amino acid-rich supplementation on EWGSOP2 criteria for sarcopenia in older adults: a systematic review and meta-analysis.

Authors:  Geng-Hao Bai; Meng-Chen Tsai; Han-Wei Tsai; Chun-Chao Chang; Wen-Hsuan Hou
Journal:  Eur J Nutr       Date:  2021-10-27       Impact factor: 5.614

Review 2.  A Guide to Different Intensities of Exercise, Vaccination, and Sports Nutrition in the Course of Preparing Elite Athletes for the Management of Upper Respiratory Infections during the COVID-19 Pandemic: A Narrative Review.

Authors:  Hamid Agha-Alinejad; Amir Hossein Ahmadi Hekmatikar; Ruheea Taskin Ruhee; Mahdieh Molanouri Shamsi; Masoud Rahmati; Kayvan Khoramipour; Katsuhiko Suzuki
Journal:  Int J Environ Res Public Health       Date:  2022-02-08       Impact factor: 3.390

3.  Individualised physical exercise training and enhanced protein intake in older citizens during municipality-based rehabilitation: protocol for a randomised controlled trial.

Authors:  Sanel Teljigovic; Karen Søgaard; Louise Fleng Sandal; Tina Dalager; Nina Odgaard Nielsen; Gisela Sjøgaard; Lars Holm
Journal:  BMJ Open       Date:  2020-11-26       Impact factor: 2.692

Review 4.  A Call to Action: Now Is the Time to Screen Elderly and Treat Osteosarcopenia, a Position Paper of the Italian College of Academic Nutritionists MED/49 (ICAN-49).

Authors:  Tiziana Montalcini; Arturo Pujia; Lorenzo M Donini; Lucia Frittitta; Fabio Galvano; Andrea Natali; Loris Pironi; Marisa Porrini; Patrizia Riso; Angela Albarosa Rivellese; Diego Russo; Giovanni Scapagnini; Mauro Serafini; Anna Tagliabue; Antonino De Lorenzo
Journal:  Nutrients       Date:  2020-08-31       Impact factor: 5.717

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.